Fig. 3

Construction and validation of the multimodal prognostic model and nomogram (A). The survival-related ROC curve analysis for migrasome-related signature and clinical factors; (B). C-index comparison of the migrasome-related risk score and other clinical factors; (C and D). The Kaplan–Meier analysis of overall survival for patients with high risk scores and low risk scores in the early-onset and later-onset subgroups; (E and F). The Kaplan–Meier analysis of overall survival for patients with high risk scores and low risk scores in the stage I-II and III-IV subgroups; (G). Construction of the nomogram based on the multimodal model; (H). The calibration curves of the nomogram for 1-, 3-, and 5-year OS.